Related Experiment Video
Updated: Jun 17, 2026
04:12
Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
Management of hirsutism
1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
Skin Therapy Letter
|December 31, 2009
Summary
Hirsutism, a condition affecting 5-10% of women, involves excess hair growth. This overview details its causes and explores current treatment strategies for managing this common endocrine disorder.
Area of Science:
- Endocrinology
- Dermatology
Background:
- Hirsutism affects 5-10% of women of reproductive age.
- It is characterized by androgen-dependent terminal hair growth in a male-like pattern.
Purpose of the Study:
- To provide a comprehensive overview of hirsutism.
- To emphasize the underlying etiologies.
- To discuss available therapeutic options.
Main Methods:
- Literature review of hirsutism.
- Analysis of etiological factors.
- Evaluation of treatment modalities.
Main Results:
- Hirsutism has diverse causes, including PCOS, adrenal hyperplasia, and tumors.
- Treatment aims to reduce hair growth and address the underlying cause.
Conclusions:
- Effective management of hirsutism requires accurate diagnosis of the etiology.
- A range of therapeutic options exist, offering management for affected individuals.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.